Analysis of amyloid plaque load, reactive gliosis, and bulk microglia RNA sequencing (Fig. 1A), indicate that rh Bri2 BRICHOS treatment is efficient at a late AD-like stage and works by targeting Aβ-induced pathology. The gene discussed is ITM2B; the disease is Alzheimer disease.